(NASDAQ: HOLX) Hologic's forecast annual revenue growth rate of 5.45% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.06%.
Hologic's revenue in 2026 is $4,126,500,000.On average, 21 Wall Street analysts forecast HOLX's revenue for 2026 to be $970,445,602,035, with the lowest HOLX revenue forecast at $915,527,355,405, and the highest HOLX revenue forecast at $1,012,192,399,270. On average, 19 Wall Street analysts forecast HOLX's revenue for 2027 to be $1,021,791,930,185, with the lowest HOLX revenue forecast at $962,632,030,360, and the highest HOLX revenue forecast at $1,072,022,033,810.
In 2028, HOLX is forecast to generate $1,082,514,544,345 in revenue, with the lowest revenue forecast at $1,012,415,644,175 and the highest revenue forecast at $1,138,995,505,310.